These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 27793048)

  • 1. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
    Tan Z; Zou Y; Zhu M; Luo Z; Wu T; Zheng C; Xie A; Wang H; Fang S; Liu S; Li Y; Lu Z
    BMC Cancer; 2021 Apr; 21(1):409. PubMed ID: 33858374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic risk stratification value of MACC1 expression in patients with gastric cancer.
    Zhang X; Feng XJ; Han QY; Zhang JG; Yan WH; Lin A
    Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Response and Metastasis-Links between the Metastasis Driver MACC1 and Cancer Immune Escape Strategies.
    Torke S; Walther W; Stein U
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: The MACC1 network in cancer.
    Walther W; Siegel F; Stein U
    Front Oncol; 2023; 13():1343812. PubMed ID: 39040129
    [No Abstract]   [Full Text] [Related]  

  • 5. MACC1-induced migration in tumors: Current state and perspective.
    Hohmann T; Hohmann U; Dehghani F
    Front Oncol; 2023; 13():1165676. PubMed ID: 37051546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer.
    Lv M; Jiao Y; Yang B; Ye M; Di W; Su W; Zhong J
    Biology (Basel); 2023 Mar; 12(3):. PubMed ID: 36979146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations.
    Joshi S; Garlapati C; Aneja R
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.
    Wang Y; Qiao L; Yang J; Li X; Duan Y; Liu J; Chen S; Li H; Liu D; Fang T; Ma J; Li X; Ye F; Wan J; Wei J; Xu Q; Guo E; Jin P; Wu M; Zhang L; Xia Y; Wu Y; Shao J; Feng Y; Zhang Q; Yang Z; Chen G; Zhang Q; Li X; Wang S; Hu J; Wang X; Tan MP; Takabe K; Kong B; Yang Q; Ma D; Gao Q
    Cancer Commun (Lond); 2021 Dec; 41(12):1373-1386. PubMed ID: 34738326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Significance of MACC1 Expression in Breast Cancer and Its Relationship to Immune Cells in the Tumor Microenvironment and Patient Survival.
    Ali DA; El-Guindy DM; Elrashidy MA; Sabry NM; Kabel AM; Gaber RA; Ibrahim RR; Samy SM; Shalaby MM; Salama SA; Abdelhai D
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p.
    Li J; Lei C; Chen B; Zhu Q
    Front Oncol; 2021; 11():671853. PubMed ID: 34221989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum MACC-1: a new biomarker for breast cancer.
    Ahmed M; Aslam M
    Oncotarget; 2020 Dec; 11(48):4521-4526. PubMed ID: 33400729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients.
    Lin A; Zhang X; Zhang RL; He XF; Zhang JG; Yan WH
    Front Oncol; 2019; 9():28. PubMed ID: 30805302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of plasma MACC1 levels on the prognostic stratification in patients with colorectal cancer.
    Lin A; Zhang RL; Zhang X; He XF; Zhang JG; Yan WH
    J Cell Mol Med; 2019 Feb; 23(2):1598-1601. PubMed ID: 30370603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of serum MACC1 in breast cancer patients.
    Tan W; Xie X; Li L; Tang H; Ye X; Chen L; Tang W; Gao J; Pan L; Zhang X; Ye F; Li X; Yang L; Xie X; Zheng W
    Oncotarget; 2016 Dec; 7(51):84408-84415. PubMed ID: 27793048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.
    Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Stein U
    World J Gastroenterol; 2015 Jan; 21(1):333-41. PubMed ID: 25574109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer.
    Wang Z; Cai M; Weng Y; Zhang F; Meng D; Song J; Zhou H; Xie Z
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1353-61. PubMed ID: 25544672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
    Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
    Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of MACC1 in Digestive System Neoplasms: A Systematic Review and Meta-Analysis.
    Wu Z; Zhou R; Su Y; Sun L; Liao Y; Liao W
    Biomed Res Int; 2015; 2015():252043. PubMed ID: 26090393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.